In order to actively respond to the initiative of improving the quality control capabilities of pharmaceutical production enterprises in Xianning, Hubei Province, China. Hubei Kornnac Pharmaceutical Co., Ltd. has taken steps to enhance the professional practical abilities of its quality control personnel and strengthen the construction of its pharmaceutical talent team. Within the company, the training focused closely on the actual work of drug testing. Key experimental projects, such as the operation and principles of precision instruments like electronic analytical balances, high-performance liquid chromatography (HPLC), and gas chromatography (GC), as well as drug physicochemical testing and microbial limit testing, were explained in detail through both operational demonstrations and theoretical analysis.
The company invited highly-qualified lecturers to provide in-depth training and guidance internally, adopting a combination of theoretical explanations and practical operations. During the theoretical sessions, the lecturers thoroughly analyzed the principles of the instruments, key points of experimental methods, and drug testing standards and regulations. In the practical sessions, the lecturers provided hands-on guidance to interns, walking them through each step-from instrument startup and debugging to sample preparation and data collection and analysis. They patiently corrected mistakes and answered questions to ensure that the interns could master the operational skills.
Through this training, the overall capabilities of our company's quality control personnel have been significantly enhanced, and the practical skills of the relevant staff have been effectively strengthened. This has provided them with a more intuitive and profound understanding of drug testing work.
Regularly conducting such training not only provides a practical platform for employees but also injects vitality into the company's talent reserve and industry development. In the future, our company will continue to optimize the training model, ensuring sufficient talent reserves for our development in the pharmaceutical industry and providing sustained momentum for the company's long-term sustainable growth.
